Upgrade to SI Premium - Free Trial

Rocket Pharmaceuticals (RCKT)

2.20 -0.14 (5.98%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Rocket Pharmaceuticals to Participate in Chardan’s 10th Annual Healthcare Conference October 15, 2026 7:00 AM - BizWire Goldman Sachs Upgrades Rocket Pharmaceuticals (RCKT) to Neutral October 8, 2026 1:30 AM - StreetInsider Rocket Pharmaceuticals updates RP-A501 Danon disease trial data October 7, 2026 9:36 AM - StreetInsider Rocket Pharmaceuticals Highlights FDA-Aligned Pivotal Phase 2 Trial and Updated Clinical Findings for RP-A501 Following Danon Disease Investor Webinar October 7, 2026 9:36 AM - BizWire Rocket Pharmaceuticals (RCKT) Reiterated at Overweight by Cantor Fitzgerald After Update on RP-A501 October 7, 2026 6:59 AM - StreetInsider Rocket Pharmaceuticals (RCKT) PT Lowered to $2.95 at Jefferies October 7, 2026 4:49 AM - StreetInsider Form 8-K ROCKET PHARMACEUTICALS, For: Sep 30 October 6, 2026 5:16 PM - SEC Filing Rocket Pharmaceuticals secures $150M credit facility with Hercules Capital October 6, 2026 4:12 PM - StreetInsider Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital October 6, 2026 4:12 PM - BizWire Needham Upgrades Rocket Pharmaceuticals (RCKT) to Buy September 16, 2026 6:14 AM - StreetInsider Form 4 ROCKET PHARMACEUTICALS, For: Sep 11 Filed by: Wilson Martin September 15, 2026 8:28 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Militello John September 15, 2026 4:51 PM - SEC Filing Form 8-K ROCKET PHARMACEUTICALS, For: Sep 15 September 15, 2026 7:07 AM - SEC Filing FDA backs Rocket Pharmaceuticals' Danon disease trial path September 15, 2026 7:00 AM - StreetInsider Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease September 15, 2026 7:00 AM - BizWire Form 144 ROCKET PHARMACEUTICALS, Filed by: Militello John September 14, 2026 3:25 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Wilson Martin September 11, 2026 4:57 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Militello John September 11, 2026 4:55 PM - SEC Filing Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy September 1, 2026 7:36 AM - StreetInsider Form 8-K ROCKET PHARMACEUTICALS, For: Aug 21 August 27, 2026 4:06 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: Aug 18 Filed by: Wilson Martin August 20, 2026 5:30 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: Aug 18 Filed by: Shah Gaurav August 20, 2026 5:26 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Shah Gaurav August 18, 2026 3:50 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Wilson Martin August 18, 2026 3:47 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Militello John August 18, 2026 3:44 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: Aug 13 Filed by: Shah Gaurav August 17, 2026 5:52 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: Aug 13 Filed by: Wilson Martin August 17, 2026 5:50 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: Aug 11 Filed by: Stevens Christopher James August 13, 2026 4:16 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: Aug 11 Filed by: Chaudhuri Sarbani August 13, 2026 4:16 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Wilson Martin August 13, 2026 4:04 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Shah Gaurav August 13, 2026 3:39 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Stevens Christopher James August 11, 2026 3:31 PM - SEC Filing Form 144 ROCKET PHARMACEUTICALS, Filed by: Chaudhuri Sarbani August 11, 2026 3:23 PM - SEC Filing Form 8-K ROCKET PHARMACEUTICALS, For: Aug 10 August 10, 2026 4:19 PM - SEC Filing Rocket Pharmaceuticals (RCKT) Tops Q2 EPS by 6c; offers guidance August 10, 2026 4:18 PM - StreetInsider Form 10-Q ROCKET PHARMACEUTICALS, For: Jun 30 August 10, 2026 4:06 PM - SEC Filing Rocket Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Progress August 10, 2026 4:00 PM - BizWire Form 4 ROCKET PHARMACEUTICALS, For: Aug 03 Filed by: Stevens Christopher James August 5, 2026 8:50 PM - SEC Filing Form 4 ROCKET PHARMACEUTICALS, For: Aug 03 Filed by: SOUTHWELL DAVID P August 5, 2026 8:46 PM - SEC Filing TD Cowen: 'Rocket's protocol modifications may be mitigating prior risks' August 3, 2026 9:03 AM - StreetInsider Form 8-K ROCKET PHARMACEUTICALS, For: Aug 03 August 3, 2026 7:42 AM - SEC Filing Rocket Pharmaceuticals reports no safety issues in first 3 RP-A501 patients August 3, 2026 7:00 AM - StreetInsider Rocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease August 3, 2026 7:00 AM - BizWire Form SCHEDULE 13G ROCKET PHARMACEUTICALS, Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC July 31, 2026 11:41 AM - SEC Filing Full Article List